ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,572, issued on Aug. 12, was assigned to Amgen Inc. (Thousand Oaks, Calif.) and Atara Biotherapeutics Inc. (South San Francisco, Calif.).
"Administration of an anti-activin-a compound to a subject" was invented by Huiquan Han (Thousand Oaks, Calif.), Christopher Michael Haqq (Newbury Park, Calif.), Isaac Ciechanover (Burlingame, Calif.), Xiaolan Zhou (Newbury Park, Calif.) and John Zhao-Nian Lu (Alhambra, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods of treating ovarian cancer in a subject by administering to the subject by evaluating the subject's expression levels of specific biomarkers or angiogenic...